EP
OXFD

Eversept Partners’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Eversept Partners’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-307,742
Closed -$5.37M – 104
2020
Q4 		$5.37M Buy
307,742
+14,465
+5% +$203K 0.63% 35
2020
Q3 		$3.43M Sell
293,277
-56,861
-16% -$755K 0.76% 29
2020
Q2 		$4.55M Buy
350,138
+177,945
+103% +$2.14M 0.62% 29
2020
Q1 		$1.59M Sell
172,193
-177,630
-51% -$2.48M 0.4% 33
2019
Q4 		$5.81M Buy
349,823
+93,823
+37% +$1.52M 1.03% 28
2019
Q3 		$4.26M Buy
+256,000
New +$3.54M 1.32% 19

Eversept Partners's OXFD Position: Q1 2021 in Review

Eversept Partners sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q1 2021, closing a stake of 307,742 shares — an estimated $5.37M sold.

Eversept Partners first reported a position in OXFD in Q3 2019 and held it in 6 quarters. The position peaked at $5.81M in Q4 2019. 0 funds tracked by Wall St. Rank hold OXFD as of Q1 2021.

  • Eversept Partners reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q1 2021 after selling out during the quarter.
  • Eversept Partners sold 307,742 Oxford Immunotec Global PLC Ordinary Shares shares in Q1 2021, an estimated $5.37M.
  • Eversept Partners first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q3 2019 and held it in 6 quarters.
  • Eversept Partners's Oxford Immunotec Global PLC Ordinary Shares position peaked at $5.81M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q1 2021.

Based on Eversept Partners's 13F filing for Q1 2021, filed 13 May 2021.